KK
Krishna Kanta Ghara
About Krishna Kanta Ghara
Data last updated:
Krishna Kanta Ghara is a Director at Seaveda Biotech Private Limited (since 2019). The companies operate in Travel and Hospitality and Consumer Goods. Seaveda Biotech Private Limited reported revenue of ₹25.3 Lakh (FY 2025). Earlier, Krishna Kanta Ghara was a Director at Psioasis Biogen Private Limited (2016–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Seaveda Biotech Private Limited U24110GJ2019PTC106491 | Director | 08 Feb 2019 | 2019 | ₹25.3 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Psioasis Biogen Private Limited U24100GJ2016PTC085812 | Director | 25 Jan 2016 | 2016 | ₹29.6 Lakh (FY 2019) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Krishna Kanta Ghara
| Name | DIN | Company | Designation |
|---|---|---|---|
| Runa Kumari | 10481246 | Seaveda Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Krishna Kanta Ghara
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Krishna Kanta Ghara
Krishna Kanta Ghara currently holds 1 directorship: Seaveda Biotech Private Limited (Director, since 08 Feb 2019, revenue ₹25.3 Lakh (FY 2025)).
Krishna Kanta Ghara was first appointed on 25 Jan 2016 as Director at Psioasis Biogen Private Limited. The most recent appointment on record is 08 Feb 2019 at Seaveda Biotech Private Limited.
Krishna Kanta Ghara held 1 earlier board appointment: Psioasis Biogen Private Limited (Director, 25 Jan 2016 to 05 Sep 2022).
The current boards of Krishna Kanta Ghara's companies include Runa Kumari (Seaveda Biotech Private Limited).